MENU
 

PRE TAX NTA |$3.75

Value as at close of business on 3 January 2024

Why this fundie is betting on luxury as recession fears mount

With top holdings in Microsoft and Alphabet, how are you reading big tech’s disappointing earnings?

We follow quarterly earnings closely, but we spend a lot more time thinking about companies’ competitive positioning over the next five to 10 years, and beyond. Alphabet and Microsoft both have core businesses with amazing competitive advantages. And we can’t forget the price versus value equation at this point, after the market sell-off.

It’s important to keep in mind that a slowing of Azure’s growth rate, which was 42 per cent (constant currency) this quarter, is inevitable over time, given the size of its revenue base. Yet, it is still the fastest growing of the three US hyperscalers. Further, Microsoft has been helping clients optimise their cloud usage, which builds value for their clients in the short-term, and through longer-term customer loyalty, value for Microsoft. We also saw this dynamic in 2020.

Alphabet grew revenue 11 per cent in constant currency terms, against 39 per cent constant currency growth in the third quarter last year – so the top line wasn’t a concern for us. Costs were elevated, but there’s a path to scaling over time; we know the model scales, it’s a question of management balancing short-term cost discipline with investment for longer-term growth.

What are your biggest takeaways from US earnings season?

The US consumer is still in good shape, especially at the higher end as shown by luxury good results and spending patterns from card companies.

Lower end is more pressured by inflationary pressures. Costs are coming back into income statements, especially in technology. Supply chains are starting to heal.

Are you concerned about the US Department of Justice preparing to probe Adobe’s $20 billion Figma deal? Do you think Adobe overpaid?

No, this was expected given the current regulatory environment and the more recent antitrust focus on tech. There is actually very little overlap between the two companies, but the scope of antitrust investigations is being pushed out at present.

At first glance, the headline figure Adobe paid for Figma appeared high. We do note that history has shown that many technology acquisitions that appeared expensive at the time have proven with time to be bargains. We also draw some comfort from the fact that the deal makes a lot of sense strategically and from Adobe’s sound history of capital allocation.

Why have you sold out of Lowe’s?

The business was over earning with sales up a third in the last two years versus a long-term trajectory of 3 per cent to 4 per cent per annum. This was a direct result of the artificial stimulus from COVID-19.

Can you succeed in this market without exposure to the energy and mining sectors?

The fund has never owned these stocks as we dislike their inherent cyclicality. We have been able to achieve our investment goal of 8 per cent to 12 per cent over the long term despite not owning them.

We accept in the short term the fund may underperform by not owning these businesses, but we always measure ourselves over a longer time frame (five years-plus) and encourage our clients to do the same.

Why are you betting on higher-end retail and luxury – LVMH, Nike – as global recession fears build?

We don’t buy companies based on short-term economic forecasts, which experience has taught us are very difficult to consistently get right. All our valuations are based on what a company will earn five years in the future and whether their competitive advantages will endure or indeed strengthen.

However, even if there is a recession in the short term, we draw comfort from both of these companies’ earnings resilience in past recessions. In addition, their current valuations we believe have already priced in a lot of potentially bad news.

What’s a stock you’re keeping an eye on but don’t own?

Sherwin Williams is a company that we have owned in the past and would love to own again at the right price. It is the largest manufacturer and distributor of paint in North America. Based in Cleveland, it has an exceptional corporate culture, controls its own distribution, its own stores, has a low-cost-to-value product and an exceptional track record of earnings growth and capital allocation.

What’s your favourite local bar or restaurant? What’s your go-to order?

Balcon – favourite order is braised lamb shoulder and they have excellent charcuterie and wine list, with excellent sommeliers.

Any good podcasts or TV shows you’ve enjoyed?

On a recent flight, a documentary on the 1992 Dream Team, the US Olympic basketball team. Names like Jordan, Johnson, Bird, Pippen, Barkley. Probably the greatest collection of sports talent in a team and made the NBA a global brand.

The Australian Financial Review is a media partner of sohnheartsandminds.com.au

 

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by AFR, published on 10 November 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Recent Posts

Read the latest insights
A curated list of HM1 investor updates, portfolio news and other interesting articles.
Read More
10 top fund managers reveal their long-term stock picks
With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors. 
Rikki Bannan – Don’t get caught up in momentum
Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.
Professor Jane Butler: Sparking Hope for Spinal Cord Injuries
In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.
Nick Griffin – The Nvidia story is not over
Nick Griffin, Founding Partner & Chief Investment Officer of Munro Partners joined the Equity Mates podcast in their Summer Series.
 

10 top fund managers reveal their long-term stock picks

With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors. 

Read More
December 28th, 2024
 

Rikki Bannan – Don’t get caught up in momentum

Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.

Read More
December 19th, 2024
 

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
December 10th, 2024
 

Nick Griffin – The Nvidia story is not over

Nick Griffin, Founding Partner & Chief Investment Officer of Munro Partners joined the Equity Mates podcast in their Summer Series.

Read More
December 9th, 2024
 

HM1 CEO Succession

Hearts and Minds Investments Limited advises that Paul Rayson intends to retire from the position of Chief Executive Officer, effective 19 February 2025.

Read More
December 5th, 2024
 

Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

Read More
November 20th, 2024
 

These rock-star stock picks could get markets talking next year

Eleven rock stars of international and local funds management took to stage – each tasked with picking and pitching one company whose shares will take off over the next year.

Read More
November 18th, 2024
 

Is anyone brave or stupid enough to bet against America?

Stock pickers have been punished for betting against the US. The choice between consensus and contrarianism on American exceptionalism is now harder than ever.

Read More
November 17th, 2024
 

Sohn: NYSE-listed Estee Lauder’s Northcape Capital pick

Northcape Capital’s Fleur Wright this gives a rare opportunity to buy a high quality company at an attractive price.

Read More
November 15th, 2024
 

Sohn ASX stock pick: Ellerston Capital’s Chris Kourtis backs Perpetual

Chris Kourtis has put his biggest bet on embattled Perpetual – picking one of the most hated stocks on the ASX – that he believes will soon be the ‘cheapest listed asset manager of scale in the universe’.

Read More
November 15th, 2024
 

AI start-ups a threat to incumbent big companies

Paul Bassat predicts emerging artificial intelligence companies will disrupt sectors and overtake established incumbent companies just as rapidly as the seismic shifts that took place when the internet emerged in the mid-1990s.

Read More
November 15th, 2024
 

Howard Marks and Sohn’s big stars reveal seven rules for investing

Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.

Read More
November 15th, 2024
 

Sohn investors position for bullish but bumpy Trump ride

Australia and the rest of the world must adjust to a new Trump presidency that will deliver an expected bull market but also disruption, with the leader in waiting prepared to “create pain” to get his way.

Read More
November 15th, 2024
 

Sohn stock picker experts name best shares to invest in for year ahead

‍Don’t overlook down and out silver miners, legacy skincare brands ready for a revival and a big financial company suffering from a severe case of shareholder wealth destruction.

Read More
November 15th, 2024
 

Eleven stock tips from Sohn to get you through 2025

“There’s no finer place for the finance festival than in the festival city,” said Matthew Grounds. He, along with fellow Barrenjoey co-executive chairman Guy Fowler and investor Gary Weiss, is one of Sohn’s driving forces.

Read More
November 15th, 2024
 

Sohn Hearts & Minds Investments fund targets $1.5bn valuation

‍Hearts & Minds Investments chair Chris Cuffe is hoping for HM1 to grow to more than $1.5bn in the next five years.

Read More
November 14th, 2024
 

Galaxy Digital CEO Mike Novogratz believes bitcoin will hit $US100k

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for cryptocurrency, says US billionaire Mike Novogratz.

Read More
November 9th, 2024
 

Why this New York hedge fund manager sees opportunity in European stocks

Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.

Read More
November 6th, 2024
 

Antipodes’ Ross says short-term wealth hinges on US election

The portfolio manager says defensive stocks pose a bigger risk than the magnificent seven for investors that are overexposed to the American sharemarket.

Read More
November 5th, 2024
 

Concentration risk key for investors: Antipodes Partners’ Vihari Ross

The concentration risk in global stock indexes that has built up during the strong rise over the past year must now be a key consideration for global investors, according to Vihari Ross.

Read More
November 5th, 2024
 

The fundie betting big on China – with help from AI

Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.

Read More
November 5th, 2024
 

Why this fundie wants you to ‘wince’ at his stock picks

When fund managers come to pitch their favourite stock at the annual Sohn Hearts & Minds conference, there are two ways they can go: they can play it safe, or they can take a risk and shock the room.

 

Read More
October 29th, 2024
 

IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.

Read More
October 27th, 2024
 

Meet the 2024 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share eleven new managers for 2024. 

Read More
October 22nd, 2024
 

Chris Kourtis is on a winning streak. Here’s his next ASX pick

Chris Kourtis of Ellerston Capital thinks he’s found another winner and thinks it’s the last chance to have a bite at the cherry before the strategy plays out.

Read More
October 21st, 2024
 

Why Ellerston Capital’s Chris Kourtis plans to back a ‘hated’ stock

Chris Kourtis of Ellerston Capital plans to tip one of the “most hated” stocks in Australia when he presents at the 2024 Sohn Hearts & Minds Conference.

Read More
October 21st, 2024
 

Alex Pollak champions rewards of disruptive investment

Alex Pollak’s funds management company Loftus Peak rode the Nvidia wave and he is now looking at more opportunities in disruptive industry stocks.

Read More
October 14th, 2024
 

Buy Hold Sell: 2 Hall of Fame investors analyse each other's best ideas

Hall of Fame alumni Chris Kourtis of Ellerston Capital joins Livewire to analyse high conviction stock picks.

Read More
October 11th, 2024
 

Sumit Gautam - Why AI won't deliver in 2025 | Scalar Gauge

Sumit Gautam is the Founder of Scalar Gauge and speaks with Equity Mates ahead of his appearance at the Sohn Hearts & Minds conference.

Read More
October 8th, 2024
 

Missed out on Nvidia and Ozempic? This fundie says it’s never too late

Northcape Capital’s Fleur Wright is still kicking herself for not owning market darlings Nvidia and Novo Nordisk, the maker of the weight loss wonder drug Ozempic, before shares of those companies rocketed in 2023.

Read More
September 30th, 2024